176. The tumor necrosis factor-alpha antagonist infliximab reduces depressive symptoms in patients with treatment resistant depression and high inflammation
Raison, C., Rutherford, R.E., Woolwine, B., Shuo, C., Schettler, P., Drake, D., Haroon, E., Miller, A.H.Volume:
26
Language:
english
Journal:
Brain, Behavior, and Immunity
DOI:
10.1016/j.bbi.2012.07.200
Date:
September, 2012
File:
PDF, 40 KB
english, 2012